<H1>Chapter DOI: 10.1208/aapsj070375<br/>Cited-By Count: 4</H1><table border="1" width="30%"><tr><td>Total References</td><td>35</td></tr><tr><td>Springer references</td><td>4</td></tr><tr><td>Non Springer references</td><td>31</td></tr><tr><td>BibStructured Count</td><td width="10%">32</td></tr><tr><td>BibUnstructured Count</td><td width="10%">3</td></tr><tr><td>DOI already available in SpringerLink</td><td>25</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>1</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>1</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>0</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>1</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibChapter</td><td>Bush LH, Hempfling WP, Burton H. Chemical properties of nicotine and other tobacco-related compounds. In: Gorrod JW, Jacob P, III, eds.<Emphasis Type="Italic">Analytical Determination of Nicotine and Related Compounds and Their Metabolites</Emphasis>. New York, NY: Elsevier, 1999:69&#8211;147.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Armstrong DW, Wang X, Lee JT, Liu YS. Enantiomeric composition of nornicotine, anatabine, and anabasine in tobacco.<Emphasis Type="Italic">Chirality</Emphasis>. 1999;11:82&#8211;84.</td><td><a href=http://dx.doi.org/10.1002/(SICI)1520-636X(1999)11:1&lt;82::AID-CHIR14&gt;3.0.CO;2-C>10.1002/(SICI)1520-636X(1999)11:1&lt;82::AID-CHIR14&gt;3.0.CO;2-C</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Crooks PA, Godin CS, Pool WF. Enantiomeric purity of nicotine in tobacco smoke.<Emphasis Type="Italic">Med Sci Res</Emphasis>. 1992;20:879&#8211;880.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Crooks PA, Dwoskin LP. Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking.<Emphasis Type="Italic">Biochem Pharmacol</Emphasis>. 1997;54:743&#8211;753.</td><td><a href=http://dx.doi.org/10.1016/S0006-2952(97)00117-2>10.1016/S0006-2952(97)00117-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Copeland JR, Adem A, Jacob P III, Nordberg A. A comparison of the binding of nicotine and nornicotine stereoisomers to nicotinic binding sites in rat brain cortex.<Emphasis Type="Italic">Naunyn Schmiedebergs Arch Pharmacol</Emphasis>. 1991;343:123&#8211;127.</td><td><a href=http://dx.doi.org/10.1007/BF00168598>10.1007/BF00168598</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Reavill C, Jenner P, Kumar R, Stolerman IP. High affinity binding of [3H](&#8211;)-nicotine to rat brain membranes and its inhibition by analogues of nicotine.<Emphasis Type="Italic">Neuropharmacology</Emphasis>. 1988;27:235&#8211;241.</td><td><a href=http://dx.doi.org/10.1016/0028-3908(88)90039-1>10.1016/0028-3908(88)90039-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Xu R, Dwoskin LP, Grinevich VP, Deacine G, Crooks PA. Neuronal nicotinic acetylcholine receptor binding affinities of boron-containing nicotine analogues.<Emphasis Type="Italic">Bioorg Med Chem Lett</Emphasis>. 2001;11:1245&#8211;1248.</td><td><a href=http://dx.doi.org/10.1016/S0960-894X(01)00193-7>10.1016/S0960-894X(01)00193-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Bardo MT, Bevins RA, Klebaur JE, Crooks PA, Dwoskin LP. Nornicotine partially substitutes for (+)-amphetamine in a drug discrimination paradigm in rats.<Emphasis Type="Italic">Pharmacol Biochem Behav</Emphasis>. 1997;58:1083&#8211;1087.</td><td><a href=http://dx.doi.org/10.1016/S0091-3057(97)00303-1>10.1016/S0091-3057(97)00303-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Green TA, Phillips SB, Crooks PA, Dwoskin LP, Bardo MT. Nornicotine pretreatment decreases intravenous nicotine self-administration in rats.<Emphasis Type="Italic">Psychopharmacology (Berl)</Emphasis>. 2000;152:289&#8211;294.</td><td><a href=http://dx.doi.org/10.1007/s002130000524>10.1007/s002130000524</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Green TA, Crooks PA, Bardo MT, Dwoskin LP. Contributory role for nornicotine neuropharmacology: nornicotine-evoked [3H]dopamine overflow from rat nucleus accumbens slices.<Emphasis Type="Italic">Biochem Pharmacol</Emphasis>. 2001;62:1597&#8211;1603.</td><td><a href=http://dx.doi.org/10.1016/S0006-2952(01)00838-3>10.1016/S0006-2952(01)00838-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Dwoskin LP, Buxton ST, Jewell AL, Crooks PA. (&#8211;)-Nornicotine increases dopamine release in a calcium-dependent manner from superfused rat striatal slices.<Emphasis Type="Italic">J Neurochem</Emphasis>. 1993;60:2167&#8211;2174.</td><td><a href=http://dx.doi.org/10.1111/j.1471-4159.1993.tb03502.x>10.1111/j.1471-4159.1993.tb03502.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Teng L, Crooks PA, Buxton ST, Dwoskin LP. Nicotinic-receptor mediation of S(&#8211;)nornicotine-evoked-3H-overflow from rat striatal slices preloaded with-3H-dopamine.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1997;283:778&#8211;787.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Kyerematen GA, Morgan M, Chattopadhyay B, deBethizy JD, Vesell ES. Disposition of nicotine and eight metabolites in smokers and nonsmokers: identification in smokers of two metabolites that are longer lived than cotinine.<Emphasis Type="Italic">Clin Pharmacol Ther</Emphasis>. 1990;48:641&#8211;651.</td><td><a href=http://dx.doi.org/10.1038/clpt.1990.208>10.1038/clpt.1990.208</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Crooks PA, Li M, Dwoskin LP. Metabolites of nicotine in rat brain after peripheral nicotine administration: cotinine, nornicotine, and norcotinine.<Emphasis Type="Italic">Drug Metab Dispos</Emphasis>. 1997;25:47&#8211;54.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Ghosheh O, Dwoskin LP, Li WK, Crooks PA. Residence times and half-lives of nicotine metabolites in rat brain after acute peripheral administration of [2&#8242;-14C]nicotine.<Emphasis Type="Italic">Drug Metab Dispos</Emphasis>. 1999;27:1448&#8211;1455.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Valette H, Bottlaender M, Doll&#233; F, Coulon C, Ottaviani M, Syrota A. Long-lasting occupancy of central nicotine acetylcholine receptors after smoking: a PET study in monkeys.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2003;84:105&#8211;111.</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.2003.01502.x>10.1046/j.1471-4159.2003.01502.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Ghosheh O, Dwoskin LP, Miller DK, Crooks PA. Accumulation of nicotine and its metabolites in rat brain after intermittent or continuous peripheral administration of [2&#8242;-14C]-nicotine.<Emphasis Type="Italic">Drug Metab Dispos</Emphasis>. 2001;29:645&#8211;651.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Risner ME, Cone EJ, Benowitz NL, Jacob P III. Effects of stereoisomers of nicotine and nornicotine on schedule controlled responding by beagle dogs and squirrel monkeys.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1988;244:807&#8211;813.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Bardo MT, Green TA, Crooks PA, Dwoskin LP. Nornicotine is self-administered intravenously by rats.<Emphasis Type="Italic">Psychopharmacology (Berl)</Emphasis>. 1999;146:290&#8211;296.</td><td><a href=http://dx.doi.org/10.1007/s002130051119>10.1007/s002130051119</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Corrigall WA, Coen KM. Nicotine maintains robust self-administration in rats on a limited-access schedule.<Emphasis Type="Italic">Psychopharmacology (Berl)</Emphasis>. 1989;99:473&#8211;478.</td><td><a href=http://dx.doi.org/10.1007/BF00589894>10.1007/BF00589894</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Middleton</span> <span style='background:#DDDDDD'>LS</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Crooks</span> <span style='background:#DDDDDD'>PA</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Wedlund</span> <span style='background:#DDDDDD'>PJ</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Cass</span> <span style='background:#DDDDDD'>WA</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Dwoskin</span> <span style='background:#DDDDDD'>LP</span></span></aug>. <span style='background:#CCCCFF'>Nornicotine inhibition of striatal dopamine transporter function via nicotinic receptor activation</span>. <span style='background:#CCFF99'><i>J Pharmacol Exp Ther</i></span>. <span style='background:#66FF66'>2005</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR22</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Crooks</span> <span style='background:#DDDDDD'>PA</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Dwoskin</span> <span style='background:#DDDDDD'>LP</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Bardo</span> <span style='background:#DDDDDD'>MT</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>inventor</span></span></aug>. <span style='background:#FFD9B3'>Nornicotine enantiomers for use as a treatment for dopamine-related conditions and disease states</span>. US patent 5776957. July 8, <span style='background:#66FF66'>1998</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Dwoskin LP, Teng L, Buxton ST, Ravard A, Deo N, Crooks PA. Minor tobacco alkaloids release [3H]dopamine from superfused rat striatal slices.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 1995;276:195&#8211;199.</td><td><a href=http://dx.doi.org/10.1016/0014-2999(95)00077-X>10.1016/0014-2999(95)00077-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Grady S, Marks MJ, Wonnacott S, Collins AC. Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum.<Emphasis Type="Italic">J Neurochem</Emphasis>. 1992;59:848&#8211;856.</td><td><a href=http://dx.doi.org/10.1111/j.1471-4159.1992.tb08322.x>10.1111/j.1471-4159.1992.tb08322.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibChapter</td><td>Crooks PA. Chemical properties of nicotine and other tobacco-related compounds. In: Gorrod JW, Jacob P, eds.<Emphasis Type="Italic">Analytical Determination of Nicotine and Related Compounds and Their Metabolites</Emphasis>. New York, NY: Elsevier, 1999;69&#8211;147.</td><td><a href=http://dx.doi.org/10.1016/B978-044450095-3/50005-X>10.1016/B978-044450095-3/50005-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Deo NM, Crooks PA. Regioselective alkylation of N-(diphenylmethylidine)-3-(aminomethyl)pyridine: a simple route to minor tobacco alkaloids and related compounds.<Emphasis Type="Italic">Tetrahedron Lett</Emphasis>. 1996;37:1137&#8211;1140.</td><td><a href=http://dx.doi.org/10.1016/0040-4039(96)00002-0>10.1016/0040-4039(96)00002-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Yus M, Soler T, Foubelo F. A new and direct synthesis of 2-substituted pyrrolidines.<Emphasis Type="Italic">J Org Chem</Emphasis>. 2001;66:6207&#8211;6208.</td><td><a href=http://dx.doi.org/10.1021/jo010419n>10.1021/jo010419n</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Loh T, Zhou J, Li X, Sim K. A novel reductive aminocyclization for the syntheses of chiral pyrrolidines: stereoselective syntheses of (S)-nornicotine adn 2-(2&#8242;-pyrrolidyl)-pyridines.<Emphasis Type="Italic">Tetrahedron Lett</Emphasis>. 1999;40:7847&#8211;7850.</td><td><a href=http://dx.doi.org/10.1016/S0040-4039(99)01606-8>10.1016/S0040-4039(99)01606-8</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Felpin FX, Girard S, Vo-Thanh G, Robins RJ, Villieras J, Lebreton J. Efficient enantiomeric synthesis of pyrrolidine and piperidine alkaloids from tobacco.<Emphasis Type="Italic">J Org Chem</Emphasis>. 2001;66:6305&#8211;6312.</td><td><a href=http://dx.doi.org/10.1021/jo010386b>10.1021/jo010386b</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Amat M, Canto M, Llor N, Bosch J. Enantioselective synthesis of 2-arylpiperidines from chiral lactams. A concise synthesis of (&#8211;)-anabasine.<Emphasis Type="Italic">Chem Comm.</Emphasis> 2002;5:526&#8211;527.</td><td><a href=http://dx.doi.org/10.1039/b200020m>10.1039/b200020m</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Balasubramanian T, Hassner A. Asymmetric synthesis of functionalized piperidine derivatives: synthesis of (S)-anatabine.<Emphasis Type="Italic">Tetrahedron Asymmetry</Emphasis>. 1998;9:2201&#8211;2205.</td><td><a href=http://dx.doi.org/10.1016/S0957-4166(98)00225-0>10.1016/S0957-4166(98)00225-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Aiqiao M, Xun X, Lanjun W, Yaozhong J. Asymmetric synthesis XV: enantioselective sytheses of (R) or (S)-alpha-substituted-(2-pyridyl) methylamines via chiral pinanone ketimine template.<Emphasis Type="Italic">Synth Comm</Emphasis>. 1991;21:2207&#8211;2212.</td><td><a href=http://dx.doi.org/10.1080/00397919108055455>10.1080/00397919108055455</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Swango JH, Bhatti BS, Qureshi MM, Crooks PA. A novel enantioselective synthesis of (S)-(&#8211;)- and (R)-(+)-nornicotine via alkylation of a chiral 2-hydroxy-3-pinanone ketimine template.<Emphasis Type="Italic">Chirality</Emphasis>. 1999;11:316&#8211;318.</td><td><a href=http://dx.doi.org/10.1002/(SICI)1520-636X(1999)11:4&lt;316::AID-CHIR9&gt;3.0.CO;2-D>10.1002/(SICI)1520-636X(1999)11:4&lt;316::AID-CHIR9&gt;3.0.CO;2-D</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Ayers JT, Sonar VN, Parkin S, Dwoskin LP, Crooks PA. (1R,2R,5R)-(+)-2alfa-hydroxypinan-3-one ketamine.<Emphasis Type="Italic">Acta Cryst Sect E</Emphasis>. 2005;E61:02682&#8211;02684.</td><td><a href=http://dx.doi.org/10.1107/S1600536805023287>10.1107/S1600536805023287</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR35</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Mehmandoust</span> <span style='background:#DDDDDD'>M</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Marazano</span> <span style='background:#DDDDDD'>C</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Das</span> <span style='background:#DDDDDD'>BC.</span></span></aug>, <span style='background:#CCCCFF'>A stereoselective route to enantiomeric 2-alkyl-1,2,3,6-tetrahydropyridines</span>. <span style='background:#CCFF99'><i>J Chem Soc Chem Commun</i></span>. <span style='background:#66FF66'>1989</span>;<span style='background:#D279FF'>1185&#8211;1144</span>.</td><td><a href=http://dx.doi.org/10.1039/c39890001185>10.1039/c39890001185</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, FirstPage, Year, ArticleTitle, Author_FamilyName_2</td><td>CrossRef</td></tr></table>